Article

Kavanagh, PV, Westphal, F, Pulver, B, Elliott, SP, Stratford, A, Halberstadt, AL and Brandt, SD (2024) Analytical and behavioral characterization of 1‐dodecanoyl‐LSD (1DD‐LSD). Drug Testing and Analysis. ISSN 1942-7611

Halberstadt, AL, Luethi, D, Hoener, MC, Trachsel, D, Brandt, SD and Liechti, ME (2022) Use of the head-twitch response to investigate the structure-activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines. Psychopharmacology. ISSN 0033-3158

Kavanagh, PV, Westphal, F, Pulver, B, Schwelm, HM, Stratford, A, Auwärter, V, Chapman, SJ, Halberstadt, AL and Brandt, SD (2022) Analytical profile of the lysergamide 1cP-AL-LAD and detection of impurities. Drug Testing and Analysis. ISSN 1942-7603

Richter, MJ, Wagmann, L, Kavanagh, PV, Brandt, SD and Meyer, MR (2022) In vitro metabolic fate of the synthetic cannabinoid receptor agonists QMMSB (quinolin-8-yl 4-methyl-3-(morpholine-4-sulfonyl)benzoate) and QMiPSB (quinolin-8-yl 4-methyl-3-[(propan-2-yl)sulfamoyl]benzoate) including isozyme mapping and carboxylesterases activity testing. Drug Testing and Analysis. ISSN 1942-7603

Richter, MJ, Wagmann, L, Brandt, SD and Meyer, MR (2022) In vitro metabolic fate of the synthetic cannabinoid receptor agonists 2F-QMPSB and SGT-233 including isozyme mapping and carboxylesterases activity testing. Journal of Analytical Toxicology. ISSN 0146-4760

Brandt, SD, Kavanagh, PV, Westphal, F, Pulver, B, Schwelm, HM, Whitelock, KM, Stratford, A, Auwärter, V and Halberstadt, AL (2022) Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD. Drug Testing and Analysis. pp. 1-16. ISSN 1942-7603

Brandt, SD, Kavanagh, PV, Westphal, F, Pulver, B, Morton, K, Stratford, A, Dowling, G and Halberstadt, AL (2021) Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1-valeroyl-d-lysergic acid diethylamide (1V-LSD). Drug Testing and Analysis. ISSN 1942-7603

Angenoorth, TJF, Stankovic, S, Niello, N, Holy, M, Brandt, SD, Sitte, HH and Maier, J (2021) Interaction profiles of central nervous system active drugs at human organic cation transporters 1-3 and human plasma membrane monoamine transporter. International Journal of Molecular Sciences, 22 (23). ISSN 1422-0067

Rudin, D, McCorvy, JD, Glatfelter, GC, Luethi, D, Szöllősi, D, Ljubišić, T, Kavanagh, PV, Dowling, G, Holy, M, Jaentsch, K, Walther, D, Brandt, SD, Stockner, T, Baumann, AL and Sitte, HH (2021) (2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice. Neuropsychopharmacology. ISSN 0893-133X

Richter, MJ, Wagmann, L, Gampfer, TM, Brandt, SD and Meyer, MR (2021) In vitro metabolic fate of the synthetic cannabinoid receptor agonists QMPSB and QMPCB (SGT-11) including isozyme mapping and esterase activity. Metabolites, 11 (8). ISSN 2218-1989

Brandt, SD, Kavanagh, PV, Westphal, F, Stratford, A, Blanckaert, P, Dowling, G, Grill, M, Schwelm, HM, Auwärter, V and Chapman, SJ (2021) Separating the wheat from the chaff: observations on the analysis of lysergamides LSD, MIPLA, and LAMPA. Drug Testing and Analysis. ISSN 1942-7603

Passie, T, Adams, HA, Logemann, F, Brandt, SD, Wiese, B and Karst, M (2021) Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers. European Neuropsychopharmacology, 44. pp. 92-104. ISSN 0924-977X

Klein, AK, Chatha, M, Laskowski, LJ, Anderson, EI, Brandt, SD, Chapman, SJ, McCorvy, JD and Halberstadt, AL (2020) Investigation of the structure-activity relationships of psilocybin analogues. ACS Pharmacology & Translational Science. ISSN 2575-9108

Brandt, SD, Kavanagh, PV, Westphal, F, Dreiseitel, W, Dowling, G, Bowden, MJ and Williamson, JPB (2020) Synthetic cannabinoid receptor agonists: analytical profiles and development of QMPSB, QMMSB, QMPCB, 2F-QMPSB, QMiPSB, and SGT-233. Drug Testing and Analysis, 13 (1). pp. 175-196. ISSN 1942-7603

Brandt, SD, Kavanagh, PV, Westphal, F, Stratford, A, Elliott, SP, Dowling, G and Halberstadt, AL (2020) Analytical profile of N-ethyl-N-cyclopropyl lysergamide (ECPLA), an isomer of lysergic acid 2,4-dimethylazetidide (LSZ). Drug Testing and Analysis, 12 (10). pp. 1514-1521. ISSN 1942-7603

Brandt, SD, Walters, HM, Partilla, JS, Blough, BE, Kavanagh, PV and Baumann, MH (2020) The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats. Psychopharmacology, 237. pp. 3703-3714. ISSN 0033-3158

Brandt, SD, Carlino, L, Kavanagh, PV, Westphal, F, Dreiseitel, W, Dowling, G, Baumann, MH, Sitte, HH and Halberstadt, AL (2020) Syntheses and analytical characterizations of novel (2-aminopropyl)benzo[b]thiophene (APBT) based stimulants. Drug Testing and Analysis, 12 (8). pp. 1109-1125. ISSN 1942-7603

Grumann, C, Henkel, K, Brandt, SD, Stratford, A, Passie, T and Auwärter, V (2020) Pharmacokinetics and subjective effects of 1P-LSD in humans after oral and intravenous administration. Drug Testing and Analysis, 12 (8). pp. 1144-1153. ISSN 1942-7603

Brandt, SD, Kavanagh, PV, Westphal, F, Stratford, A, Odland, AU, Klein, AK, Dowling, G, Dempster, NM, Wallach, J, Passie, T and Halberstadt, AL (2020) Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD). Drug Testing and Analysis, 12 (6). pp. 812-826. ISSN 1942-7603

Elliott, S, Holdbrook, T and Brandt, SD (2020) Prodrugs of new psychoactive substances (NPS): a new challenge. Journal of Forensic Sciences, 65 (3). pp. 913-920. ISSN 0022-1198

Halberstadt, AL, Chatha, M, Klein, AK, Wallach, J and Brandt, SD (2020) Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. Neuropharmacology, 167 (1). ISSN 0028-3908

Halberstadt, AL, Chatha, M, Klein, AK, McCorvy, JD, Meyer, MR, Wagmann, L, Stratford, A and Brandt, SD (2019) Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD). Neuropharmacology, 127. ISSN 0028-3908

Richter, LHJ, Menges, J, Wagmann, L, Brandt, SD, Stratford, A, Westphal, F, Flockerzi, V and Meyer, MR (2019) In vitro toxicokinetics and analytical toxicology of three novel NBOMe derivatives - Phase I and II metabolism, plasma protein binding, and detectability in standard urine screening approaches studied by means of hyphenated mass spectrometry. Forensic Toxicology. ISSN 1860-8965

Wagmann, L, Hempel, N, Richter, LHJ, Brandt, SD, Stratford, A and Meyer, MR (2019) Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings. Drug Testing and Analysis, 11 (10). pp. 1507-1521. ISSN 1942-7611

Dybek, M, Wallach, J, Kavanagh, PV, Colestock, T, Filbman, N, Dowling, G, Westphal, F, Elliott, SP, Adejare, A and Brandt, SD (2019) Syntheses and analytical characterizations of the research chemical 1-[1-(2-fluorophenyl)-2-phenylethyl]pyrrolidine (fluorolintane) and five of its isomers. Drug Testing and Analysis, 11 (8). pp. 1144-1161. ISSN 1942-7611

Brandt, SD, Kavanagh, PV, Westphal, F, Stratford, A, Elliott, SP, Dowling, G, Wallach, J and Halberstadt, AL (2019) Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD). Drug Testing and Analysis, 11 (8). pp. 1122-1133. ISSN 1942-7611

Wallach, J, Colestock, T, Agramunt, J, Claydon, MDB, Dybek, M, Filemban, N, Chatha, M, Halberstadt, AL, Brandt, SD, Lodge, D, Bortolotto, ZA and Adejare, A (2019) Pharmacological characterizations of the 'legal high' fluorolintane and isomers. Behavioural Processes. ISSN 0376-6357

Grumann, C, Henkel, K, Stratford, A, Hermanns-Clausen, M, Passie, T, Brandt, SD and Auwärter, V (2019) Validation of an LC-MS/MS method for the quantitative analysis of 1P-LSD and its tentative metabolite LSD in fortified urine and serum samples including stability tests for 1P-LSD under different storage conditions. Journal of Pharmaceutical and Biomedical Analysis. ISSN 0731-7085

Halberstadt, AL, Brandt, SD, Walther, D and Baumann, MH (2019) 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α2-adrenergic receptors. Psychopharmacology. ISSN 0033-3158

Halberstadt, AL, Chatha, M, Chapman, SJ and Brandt, SD (2019) Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice. Journal of Psychopharmacology, 33 (3). pp. 406-414. ISSN 0269-8811

Wagmann, L, Richter, LHJ, Kehl, T, Wack, F, Pettersson Bergstrand, M, Brandt, SD, Stratford, A, Maurer, HH and Meyer, MR (2019) In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures. Analytical and Bioanalytical Chemistry. ISSN 1618-2642

Halberstadt, AL, Chatha, M, Stratford, A, Grill, M and Brandt, SD (2018) Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran (“FLY”) and benzodifuran (“DragonFLY”) analogs. Neuropharmacology. ISSN 0028-3908

Halberstadt, AL, Klein, LM, Chatha, M, Valenzuela, LB, Stratford, A, Wallach, J, Nichols, DE and Brandt, SD (2018) Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA). Psychopharmacology. ISSN 0033-3158

Maier, J, Mayer, FP, Brandt, SD and Sitte, HH (2018) DARK Classics in Chemical Neuroscience: Aminorex Analogues. ACS Chemical Neuroscience, 9 (10). pp. 2484-2502. ISSN 1948-7193

Wagmann, L, Brandt, SD, Stratford, A, Maurer, HH and Meyer, MR (2018) Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidases. Drug Testing and Analysis, 11 (2). pp. 318-324. ISSN 1942-7611

Maier, J, Mayer, FP, Luethi, D, Holy, M, Jäntsch, K, Reither, H, Hirtler, L, Hoener, MC, Liechti, ME, Pifl, C, Brandt, SD and Sitte, HH (2018) The psychostimulant (±)-cis-4,4'-dimethylaminorex (4,4'-DMAR) interacts with human plasmalemmal and vesicular monoamine transporters. Neuropharmacology, 138. pp. 282-291. ISSN 0028-3908

Hutter, M, Broecker, S, Kneisel, S, Franz, F, Brandt, SD and Auwärter, V (2018) Metabolism of synthetic cannabinoid receptor agonists encountered in clinical casework: major in vivo phase I metabolites of JWH-007, JWH-019, JWH-203, JWH-307, UR-144, XLR-11, AM-2201, MAM-2201 and AM-694 in human urine using LC-MS/MS. Current Pharmaceutical Biotechnology. ISSN 1389-2010

McLaughlin, G, Baumann, MH, Kavanagh, PV, Morris, N, Power, JD, Dowling, G, Twamley, B, O’Brien, J, Hessman, G, Westphal, F, Walther, D and Brandt, SD (2018) Synthesis, analytical characterization and monoamine transporter activity of the new psychoactive substance 4-methylphenmetrazine (4-MPM), with differentiation from its ortho- and meta- positional isomers. Drug Testing and Analysis. ISSN 1942-7611

Dowling, G, Kavanagh, PV, Eckhardt, HG, Twamley, B, Hessman, G, McLaughlin, G, O’ Brien, J and Brandt, SD (2018) An approach to shortening the timeframe between the emergence of new compounds on the drugs market and the availability of reference standards: the microscale syntheses of nitrazolam and clonazolam, for use as reference materials, utilizing polymer supported reagents. Drug Testing and Analysis. ISSN 1942-7611

Klein, LM, Cozzi, NV, Daley, PF, Brandt, SD and Halberstadt, AL (2018) Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs. Neuropharmacology. ISSN 0028-3908

Mayer, FP, Burchardt, NV, Decker, AM, Partilla, JS, Li, Y, McLaughlin, G, Kavanagh, PV, Sandtner, W, Baumann, MH, Blough, BE, Brandt, SD and Sitte, HH (2017) Fluorinated phenmetrazine “legal highs” act as substrates for high-affinity monoamine transporters of the SLC6 family. Neuropharmacology. ISSN 0028-3908

Luethi, D, Kaeser, PJ, Brandt, SD, Krähenbühl, S, Hoener, MC and Liechti, ME (2017) Pharmacological profile of methylphenidate-based designer drugs. Neuropharmacology, 134 (A). pp. 133-140. ISSN 0028-3908

Michely, JA, Manier, SK, Caspar, AT, Brandt, SD, Wallach, J and Maurer, HH (2017) New psychoactive substances 3-methoxyphencyclidine (3-MeO-PCP) and 3-methoxyrolicyclidine (3-MeO-PCPy): metabolic fate elucidated with rat urine and human liver preparations and their detectability in urine by GC-MS, LC-(high resolution)-MSn, and LC-high resolution-MS/MS. Current Neuropharmacology, 15 (5). pp. 692-712. ISSN 1570-159X

Huestis, MA, Brandt, SD, Rana, S, Auwärter, V and Baumann, MH (2017) Impact of novel psychoactive substances on clinical and forensic toxicology and global public health. Clinical Chemistry. ISSN 0009-9147

Brandt, SD, Kavanagh, PV, Twamley, B, Westphal, F, Elliott, SP, Wallach, J, Stratford, A, Klein, LM, McCorvy, JD, Nichols, DE and Halberstadt, AL (2017) Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775). Drug Testing and Analysis. ISSN 1942-7611

Colestock, C, Wallach, J, Mansi, M, Filemban, N, Morris, H, Elliott, SP, Westphal, F, Brandt, SD and Adejare, A (2017) Syntheses, analytical and pharmacological characterizations of the “legal high” 4-[1-(3-methoxyphenyl)cyclohexyl]morpholine (3-MeO-PCMo) and analogues. Drug Testing and Analysis. ISSN 1942-7611

Power, JD, Kavanagh, P, McLaughlin, G, Barry, M, Dowling, D and Brandt, SD (2017) ‘APAAN in the neck’ - A reflection on some novel impurities found in seized materials containing amphetamine in Ireland during routine forensic analysis. Drug Testing and Analysis, 9 (7). pp. 966-976. ISSN 1942-7611

Caspar, AT, Gaab, JB, Michely, JA, Brandt, SD, Meyer, MR and Maurer, HH (2017) Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5- MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MSn, and LC-HR-MS/MS. Drug Testing and Analysis. ISSN 1942-7611

Brandt, SD, Kavanagh, PV, Westphal, F, Elliott, SP, Wallach, J, Stratford, A, Nichols, DE and Halberstadt, AL (2017) Return of the lysergamides. Part III: Analytical characterization of N6-ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD). Drug Testing and Analysis. ISSN 1942-7611

Brunt, TM, Atkinson, AM, Nefau, T, Martinez, M, Lahaie, E, Malzcewski, A, Pazitny, M, Belackova, V and Brandt, SD (2017) Online test purchased new psychoactive substances in 5 different European countries; a snapshot study of chemical composition and price. International Journal of Drug Policy, 44. pp. 105-114. ISSN 0955-3959

Texter, KB, Waymach, R, Kavanagh, PV, O’Brien, JE, Talbot, B, Brandt, SD and Gardner, EA (2017) Identification of pyrolysis products of the new psychoactive substance 2-amino-1-(4-bromo-2,5- dimethoxyphenyl)ethan-1-one (bk-2C-B) and its iodo analog bk-2C-I. Drug Testing and Analysis. ISSN 1942-7611

Wallach, J, Morris, H and Brandt, SD (2017) Is nitrogen mustard contamination responsible for the reported MT-45 toxicity? British Journal of Dermatology. ISSN 1365-2133

Wagmann, L, Brandt, SD, Kavanagh, PV, Maurer, HH and Meyer, MR (2017) In vitro monoamine oxidase inhibition potential of alpha- methyltryptamine analog new psychoactive substances for assessing possible toxic risks. Toxicology Letters, 272. pp. 84-93. ISSN 0378-4274

McLaughlin, G, Morris, N, Kavanagh, PV, Power, JD, Dowling, G, Twamley, B, O’Brien, J, Hessman, G, Murphy, B, Walther, D, Partilla, JS, Baumann, MH and Brandt, SD (2017) Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (±)-threo- and (±)-erythro- diastereomers. Drug Testing and Analysis, 9 (3). pp. 347-357. ISSN 1942-7611

McLaughlin, G, Morris, N, Kavanagh, PV, Power, JD, Dowling, G, Twamley, B, O’Brien, J, Talbot, B, Walther, D, Partilla, JS, Baumann, MH and Brandt, SD (2017) Synthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N-methoxy positional isomer, N-methoxymephedrone. Drug Testing and Analysis, 9 (3). pp. 358-368. ISSN 1942-7611

Caspar, AT, Brandt, SD, Stoever, AE, Meyer, MR and Maurer, HH (2017) Metabolic fate and detectability of the new psychoactive substances 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethan-amine (25B-NBOMe) and 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) in human and rat urine by GC-MS, LC-MSn, and LC-HR-MS/MS approaches. Journal of Pharmaceutical and Biomedical Analysis, 134. pp. 158-169. ISSN 0731-7085

Shekar, A, Aguilar, JI, Galli, G, Cozzi, NV, Brandt, SD, Ruoho, AE, Baumann, MH, Matthies, HJG and Galli, A (2017) Atypical dopamine efflux caused by3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporter. Journal of Chemical Neuroanatomy. ISSN 0891-0618

Michely, JA, Brandt, SD, Meyer, MR and Maurer, HH (2017) Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MSn, and LC-HR-MS/MS. Analytical and Bioanalytical Chemistry, 409 (6). pp. 1681-1695. ISSN 1618-2642

Klare, H, Neudörfl, JM, Brandt, SD, Mischler, E, Meier-Giebing, S, Deluweit, K, Westphal, F and Laussmann, T (2017) Analysis of six “neuro-enhancing” phenidate analogs. Drug Testing and Analysis. ISSN 1942-7611

Dowling, G, Kavanagh, PV, Talbot, B, O’Brien, J, Hessman, G, McLaughlin, G, Twamley, B and Brandt, SD (2016) Outsmarted by nooptropics? An investigation into the thermal degradation of modafinil, modafinic acid, adrafinil, CRL-40,940 and CRL-40,941 in the GC injector: formation of 1,1,2,2-tetraphenylethane and its tetra fluoro analog. Drug Testing and Analysis, 9 (3). pp. 518-528. ISSN 1942-7611

Kang, H, Park, P, Bortolotto, ZA, Brandt, SD, Colestock, T, Wallach, J, Collingridge, GL and Lodge, D (2016) Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties. Neuropharmacology, 112 (A). pp. 144-149. ISSN 1873-7064

Elliott, SP, Brandt, SD and Smith, C (2016) The first reported fatality associated with the synthetic opioid 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) and implications for forensic analysis. Drug Testing and Analysis, 8 (8). pp. 875-879. ISSN 1942-7611

Wallach, J, Kang, H, Colestock, T, Morris, H, Bortolotto, ZA, Collingridge, GL, Lodge, D, Halberstadt, AL, Brandt, SD and Adejare, A (2016) Pharmacological Investigations of the Dissociative ‘Legal Highs’ Diphenidine, Methoxphenidine and Analogues. PLoS One, 11 (6). ISSN 1932-6203

Brandt, SD, Kavanagh, PV, Westphal, F, Elliott, SP, Wallach, J, Colestock, T, Burrow, TE, Chapman, SJ, Stratford, A, Nichols, DE and Halberstadt, AL (2016) Return of the lysergamides. Part II: Analytical and behavioural characterization of N6-allyl-6-norlysergic acid diethylamide (AL-LAD) and (2’S,4’S)-lysergic acid 2,4-dimethylazetidide (LSZ). Drug Testing and Analysis. ISSN 1942-7611

Elliott, SP, Brandt, SD and Smith, C (2016) The first reported fatality associated with the synthetic opioid 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) and implications for forensic analysis. Drug Testing and Analysis. ISSN 1942-7611

Brandt, SD, Kavanagh, PV, Dowling, G, Talbot, B, Westphal, F, Meyer, MR, Maurer, HH and Halberstadt, AL (2016) Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives. Drug Testing and Analysis. ISSN 1942-7611

Franz, F, Angerer, V, Brandt, SD, McLaughlin, G, Kavanagh, PV, Moosmann, B and Auwärter, V (2016) In vitro metabolism of the synthetic cannabinoid 3,5-AB-CHMFUPPYCA and its 5,3-regioisomer and investigation of their thermal stability. Drug Testing and Analysis. ISSN 1942-7611

McLaughlin, G, Morris, N, Kavanagh, PV, Dowling, G, Power, JD, Twamley, B, O'Brien, J, Talbot, B, Sitte, HH and Brandt, SD (2016) Test purchase, synthesis and characterization of 3-fluorophenmetrazine (3-FPM) and differentiation from its ortho- and para-substituted isomers. Drug Testing and analysis. ISSN 1942-7611

Dinger, J, Woods, C, Brandt, SD, Meyer, MR and Maurer, HH (2016) Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class. Toxicology Letters, 241. pp. 82-94. ISSN 0378-4274

Power, JD, Kavanagh, P, McLaughlin, G, Dowling, G, Barry, M, O'Brien, J, Talbot, B, Twamley, B and Brandt, SD (2016) Forensic analysis of P2P derived amphetamine synthesis impurities: identification and characterization of indene by-products. Drug Testing and Analysis. ISSN 1942-7611

McLaughlin, G, Morris, N, Kavanagh, PV, Power, JD, O'Brien, J, Talbot, B, Elliott, SP, Wallach, J, Hoang, K, Morrish, H and Brandt, SD (2016) Test purchase, synthesis, and characterization of 2-methoxydiphenidine (MXP) and differentiation from its meta- and para-substituted isomers. DRUG TESTING AND ANALYSIS, 8 (1). pp. 98-109. ISSN 1942-7603

Brandt, SD, Kavanagh, PV, Westphal, F, Stratford, A, Elliott, SP, Hoang, K, Wallach, J and Halberstadt, AL (2015) Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD). Drug Testing and analysis. ISSN 1942-7611

Power, JD, Kavanagh, P, McLaughlin, G, O'Brien, J, Talbot, B, Barry, M, Twamley, B, Dowling, G and Brandt, SD (2015) Identification and characterization of an imidazolium by-product formed during the synthesis of 4-methylmethcathinone (mephedrone). DRUG TESTING AND ANALYSIS, 7 (10). pp. 894-902. ISSN 1942-7603

Michely, JA, Helfer, AG, Brandt, SD, Meyer, MR and Maurer, HH (2015) Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MS (n) , and LC-HR-MS-MS. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 407 (25). pp. 7831-7842. ISSN 1618-2642

Wallach, J, Colestock, T, Cicali, B, Elliott, SP, Kavanagh, PV, Adejare, A, Dempster, NM and Brandt, SD (2015) Syntheses and analytical characterizations of N-alkyl-arylcyclohexylamines. Drug Testing and Analysis. ISSN 1942-7611

McLaughlin, G, Morris, N, Kavanagh, PV, Power, JD, Twamley, B, O'Brien, J, Talbot, B, Dowling, G and Brandt, SD (2015) The synthesis and characterization of the 'research chemical' N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide (3,5-AB-CHMFUPPYCA) and differentiation from its 5,3-regioisomer. Drug Testing and Analysis. ISSN 1942-7611

Marusich, JA, Antonazzo, KR, Blough, BE, Brandt, SD, Kavanagh, PV, Partilla, JS and Baumann, MH (2015) The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue. Neuropharmacology, 101. pp. 68-75. ISSN 0028-3908

Caspar, AT, Helfer, AG, Michely, JA, Auwaerter, V, Brandt, SD, Meyer, MR and Maurer, HH (2015) Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MSn, and LC-HR-MS/MS. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 407 (22). pp. 6697-6719. ISSN 1618-2642

Schindler, CW, Thorndike, EB, Goldberg, SR, Lehner, KR, Cozzi, NV, Brandt, SD and Baumann, MH (2015) Reinforcing and neurochemical effects of the "bath salts" constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats. Psychopharmacology, 233. pp. 1981-1990. ISSN 1432-2072

Nichols, DE, Sassano, MF, Halberstadt, AL, Klein, LM, Brandt, SD, Elliott, SP and Fiedler, WJ (2015) N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylarnine Analogues. ACS CHEMICAL NEUROSCIENCE, 6 (7). pp. 1165-1175. ISSN 1948-7193

Elliott, SP, Brandt, SD, Wallach, J, Morris, H and Kavanagh, PV (2015) First Reported Fatalities Associated with the 'Research Chemical' 2-Methoxydiphenidine. JOURNAL OF ANALYTICAL TOXICOLOGY, 39 (4). pp. 287-293. ISSN 0146-4760

Welter, J, Brandt, SD, Kavanagh, P, Meyer, MR and Maurer, HH (2015) Metabolic fate, mass spectral fragmentation, detectability, and differentiation in urine of the benzofuran designer drugs 6-APB and 6-MAPB in comparison to their 5-isomers using GC-MS and LC-(HR)-MSn techniques. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 407 (12). pp. 3457-3470. ISSN 1618-2642

Wallach, J, Kavanagh, PV, Mclaughlin, G, Morris, N, Power, JD, Elliott, SP, Mercier, MS, Lodge, D, Morris, H, Dempster, NM and Brandt, SD (2015) Preparation and characterization of the 'research chemical' diphenidine, its pyrrolidine analogue, and their 2,2-diphenylethyl isomers. Drug Testing and Analysis, 7 (5). pp. 358-367. ISSN 1942-7603

Brandt, SD, Elliott, SP, Kavanagh, PV, Dempster, NM, Meyer, MR, Maurer, HH and Nichols, DE (2015) Analytical characterization of bioactive N-benzyl-substituted phenethylamines and 5-methoxytryptamines. RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 29 (7). pp. 573-584. ISSN 0951-4198

Monograph

Brandt, SD (2023) Critical Review Report: 2-Methyl AP-237. Technical Report. World Health Organisation.

Brandt, SD (2023) Critical Review Report: α-Pyrrolidinoisohexanophenone (α-PiHP). Technical Report. World Health Organisation.

De Morais, J, Brandt, SD, Jorge, R, Christie, R, Gallegos, A, Sedefov, R and Evans-Brown, M (2020) EMCDDA technical report on the new psychoactive substance methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (4F-MDMB-BICA). Technical Report. European Monitoring Centre for Drugs and Drug Addiction.

De Morais, J, Brandt, SD, Jorge, R, Christie, R, Gallegos, A, Sedefov, R and Evans-Brown, M (2020) EMCDDA technical report on the new psychoactive substance methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-carbonyl]amino}butanoate (MDMB-4en-PINACA). Technical Report. European Monitoring Centre for Drugs and Drug Addiction.

Brandt, SD (2019) Critical Review Report: 4F-MDMB-BINACA. Technical Report. World Health Organisation, Geneva, Switzerland.

Brandt, SD (2019) Critical Review Report: 5F-MDMB-PICA. Technical Report. World Health Organisation, Geneva, Switzerland.

Brandt, SD (2019) Critical Review Report: DOC (4-Chloro-2,5-dimethoxyamfetamine). Technical Report. World Health Organisation, Geneva, Switzerland.

Brandt, SD (2018) Critical Review Report: p-Fluoro-butyrylfentanyl. Technical Report. World Health Organisation.

Brandt, SD (2018) Critical Review Report: p-Methoxy-butyrylfentanyl. Technical Report. World Health Organisation.

Brandt, SD (2018) N-Ethylnorpentylone. Critical Review Report. Technical Report. World Health Organisation.

Brandt, SD, Elliott, S, Evans-Brown, M, Valur Danielsson, H, Almeida, A, Gallegos, A, Jorge, R, Christie, R, de Morais, J, Sola, S and Sedefov, R (2017) Technical report on 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA). Annex 1 to the Risk Assessment Report on 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3- carboxamide (CUMYL-4CN-BINACA). Technical Report. European Monitoring Centre for Drugs and Drug Addiction.

Brandt, SD, Elliott, S, Evans-Brown, M, Valur Danielsson, H, Almeida, A, Jorge, R, Christie, R, de Morais, J, Sola, S, Gallegos, A and Sedefov, R (2017) Technical report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3- carboxamide (ADB-CHMINACA). Annex 1 to the Risk Assessment Report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA). Technical Report. European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

Brandt, SD, Elliott, S, Evans-Brown, M, Valur Danielsson, H, Almeida, A, Jorge, R, Christie, R, Gallegos, A and Sedefov, R (2017) Technical report on N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyrylfentanyl; 4F-iBF). Annex 1 to the Risk Assessment Report on N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyrylfentanyl; 4F-iBF). Technical Report. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon.

Brandt, SD, Elliott, S, Evans-Brown, M, Valur Danielsson, H, Almeida, A, Jorge, R, Christie, R, Sola, S, Gallegos, A and Sedefov, R (2017) Technical report on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2-carboxamide (tetrahydrofuranylfentanyl; THF-F). Annex 1 to the Risk Assessment Report on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2- carboxamide (tetrahydrofuranylfentanyl). Technical Report. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon.

Brandt, SD, Elliott, S, Valur Danielsson, H, Almeida, A, Gallegos, A, Jorge, R, Christie, R, Evans-Brown, M and Sedefov, R (2017) Furanylfentanyl. ANNEX 1. Technical report on N-phenyl-N- [1-(2-phenylethyl)piperidin-4-yl]furan- 2-carboxamide (furanylfentanyl). Technical Report. European Monitoring Centre for Drugs and Drug Addiction, Luxembourg.

Brandt, SD (2017) 4-Fluoroamphetamine (4-FA). A Critical Review Report. Technical Report. World Health Organization.

Brandt, SD (2017) 5F-PB-22. Critical Review Report. Technical Report. World Health Organization.

Brandt, SD (2017) AB-PINACA. Critical Review Report. Technical Report. World Health Organization.

Brandt, SD (2016) 4-Methylethcathinone (4-MEC). Critical Review Report. Agenda Item 4.3. Technical Report. Word Health Organisation.

Brandt, SD (2016) XLR-11. Critical Review Report. Agenda Item 4.12. Technical Report. World Health Organization.

Brandt, SD and Elliott, S (2016) Technical report on 1-phenyl-2- (pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP). Technical Report. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

Brandt, SD (2015) Technical report on 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-dimethylaminorex, 4,4’-DMAR). Annex 1 to the “Risk assessment report of a new psychoactive substance: 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-dimethylaminorex, 4,4’-DMAR). Technical Report. European Monitoring Centre for Drugs and Drug Addiction, Luxembourg.

Brandt, SD (2015) 1-Phenyl-2-(pyrrolidin-1-yl)pentan-1- one (α-PVP). Critical Review Report. Technical Report. World Health Organization (WHO).

Brandt, SD (2015) 4-Fluoroamphetamine (4-FA). Critical Review Report. Technical Report. World Health Organization (WHO).

Brandt, SD (2014) 4‐Fluoromethcathinone (flephedrone; 4‐FMC). Critical Review Report. Agenda item 4.16. Expert Committee on Drug Dependence. Thirty‐sixth Meeting. Geneva, 16‐20 June 2014 (World Health Organization). Technical Report. World Health Organization (WHO).

Brandt, SD (2014) 4‐Methylethcathinone (4‐MEC). Critical Review Report. Agenda item 4.15. (R/S)-2‐(Ethylamino)‐1‐(4‐methylphenyl) propan‐1‐one (4‐methyl‐N‐ethylcathinone, 4‐MEC). Expert Committee on Drug Dependence. Thirty‐sixth Meeting. Geneva, 16‐20 June 2014 (World Health Organization). Technical Report. World Health Organization (WHO).

Elliott, S and Brandt, SD (2014) Technical report on 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe). Annex 2 to the “Risk Assessment Report of a new psychoactive substance: 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe)”. Technical Report. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

Herraiz, T and Brandt, SD (2014) Study examining the inhibition of human monoamine oxidase (MAO) by the new psychoactive substance 5-(2-aminopropyl)indole (5-IT). Annex 2 to the “5-(2-Aminopropyl)indole (5-IT): Report on the risk assessment
of 5-(2-aminopropyl)indole in the framework of the Council Decision on new psychoactive substances”. Technical Report. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon.